| Dr Edwin Numsuwan, MD | |
|
102 Irving St Nw, Washington, DC 20010-2921 | |
| (202) 877-1964 | |
| Not Available |
| Full Name | Dr Edwin Numsuwan |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 22 Years |
| Location | 102 Irving St Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598853202 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 249594 (New York) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 249594 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sibley Memorial Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and underutilization of intrathecal baclofen (ITB) therapy from Medtronic, Inc. as a treatment option for these patients.
New results published today in the New England Journal of Medicine about a large-scale Phase III trial conducted in seven African countries of the malaria vaccine candidate RTS,S deserve a hearty round of applause.
Established and designated by the National Cancer Institute as one of eight original comprehensive cancer centers in 1973, the Duke Cancer Institute (DCI) is now among just 41 cancer centers in the United States to hold that distinction.
› Verified 5 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000415 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and underutilization of intrathecal baclofen (ITB) therapy from Medtronic, Inc. as a treatment option for these patients.
New results published today in the New England Journal of Medicine about a large-scale Phase III trial conducted in seven African countries of the malaria vaccine candidate RTS,S deserve a hearty round of applause.
Established and designated by the National Cancer Institute as one of eight original comprehensive cancer centers in 1973, the Duke Cancer Institute (DCI) is now among just 41 cancer centers in the United States to hold that distinction.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edwin Numsuwan, MD 102 Irving St Nw, Washington, DC 20010-2921 Ph: (202) 877-1964 | Dr Edwin Numsuwan, MD 102 Irving St Nw, Washington, DC 20010-2921 Ph: (202) 877-1964 |
News Archive
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today publication of data demonstrating that its sapacitabine oral nucleoside analog works synergistically with histone deacetylase (HDAC) inhibitors to induce significant reductions in tumor cell growth in both in vitro and in vivo preclinical models.
A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and underutilization of intrathecal baclofen (ITB) therapy from Medtronic, Inc. as a treatment option for these patients.
New results published today in the New England Journal of Medicine about a large-scale Phase III trial conducted in seven African countries of the malaria vaccine candidate RTS,S deserve a hearty round of applause.
Established and designated by the National Cancer Institute as one of eight original comprehensive cancer centers in 1973, the Duke Cancer Institute (DCI) is now among just 41 cancer centers in the United States to hold that distinction.
› Verified 5 days ago
Thomas Fong-jen Chang, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-3094 | |
Dr. Nikolai Dmitrievich Khromouchkine, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2150 Pennsylvania Ave Nw Fl 7, Washington, DC 20037 Phone: 202-741-2439 Fax: 202-741-2721 | |
Dr. Jennifer Semel-concepcion, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: Medstar National Rehabilitation Hospital, 102 Irving Street, Washington, DC 20010 Phone: 202-877-1504 | |
Dr. Eric Wisotzky, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 102 Irving St Nw, Washington, DC 20010 Phone: 202-877-1621 | |
Janaki Kalyanam, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-1411 Fax: 202-865-4724 | |
Dr. Mehul Jagdish Desai, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2141 K St Nw, Suite 600, Washington, DC 20037 Phone: 202-808-8295 Fax: 202-808-8296 | |
Dr. Paul F. Pasquina, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: Physical Medicine Rehabilitation, Walter Reed Army Medical Center, 6900 Georgia Ave, Washington, DC 20307 Phone: 202-782-6369 |